New insights into frequency and contents of fear of cancer progression/recurrence (FOP/FCR) in outpatients with colorectal carcinoma (CRC) receiving oral capecitabine: a pilot study at a comprehensive cancer center

BACKGROUND: Fear of cancer progression/recurrence (FOP/FCR) is considered one of the most prevalent sources of distress in cancer survivors and associated with lower quality of life and functional impairment. Detailed measures of FOP/FCR are needed because little is known about the knowledge of FOP/...

Descripción completa

Detalles Bibliográficos
Autores principales: Hefner, Jochen, Berberich, Sara, Lanvers, Elena, Sanning, Maria, Steimer, Ann-Kathrin, Kunzmann, Volker
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5694194/
https://www.ncbi.nlm.nih.gov/pubmed/29180853
http://dx.doi.org/10.2147/PPA.S142784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5694194/
https://www.ncbi.nlm.nih.gov/pubmed/29180853
http://dx.doi.org/10.2147/PPA.S142784

Ejemplares similares